|
|
| (One intermediate revision by one other user not shown) |
| Line 1: |
Line 1: |
| __NOTOC__
| | #REDIRECT [[Methyldopa#Drug Interactions]] |
| {{Methyldopa}}
| |
| {{CMG}}; {{AE}} {{AK}}
| |
| | |
| ==DRUG INTERACTIONS==
| |
| | |
| When methyldopa is used with other [[antihypertensive ]]drugs, potentiation of antihypertensive effect may occur. Patients should be followed carefully to detect side reactions or unusual manifestations of drug idiosyncrasy.
| |
| | |
| Patients may require reduced doses of anesthetics when on methyldopa. If hypotension does occur during [[anesthesia]], it usually can be controlled by [[vasopressors]]. The adrenergic receptors remain sensitive during treatment with methyldopa.
| |
| | |
| When methyldopa and lithium are given concomitantly, the patient should be carefully monitored for symptoms of lithium toxicity. Read the circular for [[lithium ]]preparations.
| |
| | |
| Several studies demonstrate a decrease in the bioavailability of methyldopa when it is ingested with [[ferrous sulfate]] or [[ferrous gluconate]]. This may adversely affect blood pressure control in patients treated with methyldopa. Coadministration of methyldopa with ferrous sulfate or ferrous gluconate is not recommended.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = METHYLDOPA TABLET [CARDINAL HEALTH] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d87d63fd-48f7-4130-af03-5e263c338fe4 | publisher = | date = | accessdate = 10 March 2014 }}</ref>
| |
| | |
| ==References==
| |
| | |
| {{Reflist|2}}
| |
| | |
| [[Category:Cardiovascular Drugs]]
| |
| [[Category:Drugs]]
| |